CLASS III ONGOING Drug recall · Reported 4 Nov 2026 · FDA Enforcement Report
Vecuronium Bromide for Injection, 20mg-Dose Vials per, Sterile recalled
Meitheal Pharmaceuticals is recalling Vecuronium Bromide for Injection, 20mg-Dose Vials per, Sterile, distributed nationwide in the US. The recall was initiated on 8 Oct 2026 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0109-2027
- FDA event ID
- 100110
- Recalling firm
- Meitheal Pharmaceuticals, Chicago, IL
- Brand
- Vecuronium Bromide
- Manufacturer
- Meitheal Pharmaceuticals Inc.
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- 8 Oct 2026
- FDA classified
- 29 Oct 2026
- Reported
- 4 Nov 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Injectable & IV Drugs
Timeline
| 8 Oct 2026 | Recall initiated by company | |
| 29 Oct 2026 | Classified by FDA | +21 days |
| 4 Nov 2026 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Label Lacks Warning or Rx Legend
Product as listed by the FDA
Vecuronium Bromide for Injection, 20mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL. NDC: 71288-745-21
Where it was distributed
US. Nationwide
Questions about this recall
Why was it recalled?
Labeling: Label Lacks Warning or Rx Legend
Which lots are affected?
Lot# T1P0113C: Exp. 28-Feb-29 Lot# T1P0612C: Exp. 31-Oct-28
Where was it sold?
US. Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 10 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 100110This product is part of a recall event; the main page for the event is Vecuronium Bromide for Injection, 10mg-Dose Vials per, Sterile recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS III | Vecuronium Bromide for Injection, 10mg-Dose Vials per, Sterile recalledVecuronium Bromide | Meitheal Pharmaceuticals | Other | Nationwide |
More recalls from Meitheal Pharmaceuticals
All 5| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Vecuronium Bromide for Injection, 10mg-Dose Vials per, Sterile recalledVecuronium Bromide | Meitheal Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | Cetrorelix Acetate for Injection , 0.25 mg per vial, Single-Dose Kit recalled | Meitheal Pharmaceuticals | Other | Nationwide |
| Drug | CLASS III | Glycopyrrolate Injection, USP 4mg per Multi-Dose Vials recalled | Meitheal Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS I | Cisatracurium Besylate Injection, USP, 10mg recalledCisatracurium Besylate | Meitheal Pharmaceuticals | Labeling Errors | Nationwide |
Other Vecuronium recalls
All 12| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Vecuronium Bromide for Injection, 10mg-Dose Vials per, Sterile recalledVecuronium Bromide | Meitheal Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | vecuronium, 10 mg/, (1 mg/mL) syringe recalled | Central Admixture Pharmacy Services | Sterility | Nationwide |
| Drug | CLASS II | Vecuronium Bromide for Injection, 10 mg (1mg/ mL) vial recalled | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Vecuronium Bromide for Injection, 10 mg recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |
| Drug | CLASS I | Vecuronium Bromide for Injection 20 mg* *1mg/mL when recalledVecuronium Bromide | Sun Pharmaceutical Industries | Particulate Matter | Nationwide |